Extubation failure carries significant morbidity and mortality, and current evidence-based guidelines recommend NIV for select patients following extubation. This session examines the evidence behind those recommendations, explores patient selection criteria, and offers practical guidance on interface selection and the role of high-flow nasal oxygen as a complementary or alternative strategy. By the end of this session, participants will be able to:
Learn more about recommended NIV guidelines following extubation